Citation Impact
Citing Papers
Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA.
1991
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Intratumor microvessel density as a prognostic factor in cancer.
1995
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
2009
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
1994
The relationship between prognostic and predictive factors in the management of breast cancer
1998
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
2005 StandoutNobel
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
2004 Standout
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Randomized Comparison of Minimally Invasive Direct Coronary Artery Bypass Surgery Versus Sirolimus-Eluting Stenting in Isolated Proximal Left Anterior Descending Coronary Artery Stenosis
2009
Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes
2005 Standout
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Human schistosomiasis
2006 Standout
Improved outcome with novel device for low-pressure PTCA in de novo and in-stent lesions
2003
Mechanotransduction and extracellular matrix homeostasis
2014 Standout
Sirolimus-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal Stents
2006
Optical control of antibacterial activity
2013 StandoutNobel
Interobserver Reproducibility of Cervical Cytologic and Histologic Interpretations<SUBTITLE>Realistic Estimates From the ASCUS-LSIL Triage Study</SUBTITLE>
2001
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with high clinical follow-up event rates compared with treatment of native vessels
2007
Angiogenesis and metastasis
1996
Revascularization in severe left ventricular dysfunction: Outcome comparison of drug‐eluting stent implantation versus coronary artery by‐pass grafting
2007
Drug-eluting stents in vascular intervention
2003
Outcomes of repeat revascularization in diabetic patients with prior coronary surgery
2002
Late coronary stent thrombosis: Early vs. late stent thrombosis in the stent era
2002
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients
2009
Female genital schistosomiasis: facts and hypotheses
2001
Potential impact of application of Z0011 derived criteria to omit axillary lymph node dissection in node positive breast cancer patients
2016
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Safety Pharmacology of DW‐224a, A Novel Fluoroquinolone Antibiotic Agent
2004
Persistent delta antigenaemia in chronic delta hepatitis and its relation with human immunodeficiency virus infection
1992
Kappa statistics to measure interrater and intrarater agreement for 1790 cervical biopsy specimens among twelve pathologists: Qualitative histopathologic analysis and methodologic issues
2005
Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery
2006 Standout
Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis
1995
Human papillomavirus and cervical cancer
2007 Standout
Clinical Applications of Research on Angiogenesis
1995 Standout
Development and Duration of Human Papillomavirus Lesions, after Initial Infection
2005
Endovascular Gamma Irradiation of Femoropopliteal de Novo Stenoses Immediately after PTA: Interim Results of Prospective Randomized Controlled Trial
2002
Angiogenesis and breast cancer metastasis
1995
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Guidelines for Percutaneous Coronary Interventions
2005
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Two-Year Outcomes After Sirolimus-Eluting Stent Implantation
2006
p16INK4a Immunohistochemistry Improves Interobserver Agreement in the Diagnosis of Cervical Intraepithelial Neoplasia
2002 Standout
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
2011 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
2009 Standout
Impact of renal function on morbidity and mortality after percutaneous aortocoronary saphenous vein graft intervention
2003
A comparison of short- and long-term outcomes for balloon angioplasty and coronary stent placement
2000
The carboxy‐terminus of the hepatitis B virus X protein is necessary and sufficient for the activation of hypoxia‐inducible factor‐1α
2004
Effectiveness of sirolimus-eluting stent implantation for treatment of in-stent restenosis after brachytherapy failure
2004
Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen
1995
Tomographic imaging using the nonlinear response of magnetic particles
2005 StandoutNature
Effectiveness of Drug-Eluting Stents in Patients With Bare-Metal In-Stent Restenosis
2006
Hybrid Cardiovascular Procedures
2008
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 Standout
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
2002 StandoutNobel
Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
2003 Standout
Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent Restenosis
2005
Can we prevent in-stent restenosis?
2002
Implantation and the placenta: key pieces of the development puzzle
1994 StandoutScience
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Advances in Coronary Angioplasty
1996
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Outcome of Reoperative Coronary Bypass Surgery Versus Coronary Angioplasty After Previous Bypass Surgery
1997
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
2005 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
The Coronary Angiogram and Its Seminal Contributions to Cardiovascular Medicine Over Five Decades
2002
Endovascular Brachytherapy after Percutaneous Transluminal Angioplasty of Recurrent Femoropopliteal Obstructions
2003
Comparison of Bare-Metal Stenting With Minimally Invasive Bypass Surgery for Stenosis of the Left Anterior Descending Coronary Artery
2005
ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org
1999
Endovascular Brachytherapy for Prophylaxis of Restenosis After Femoropopliteal Angioplasty
2000
Pathological Mechanisms of Fatal Late Coronary Stent Thrombosis in Humans
2003
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles
1997 StandoutNobel
Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer.
1999
Evidence based medicine: what it is and what it isn't
1996 Standout
A critical role for elastin signaling in vascular morphogenesis and disease
2002
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis
2017 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Fluorine in medicine
2004
Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
1997 StandoutNobel
Mitochondria as Functional Targets of Proteins Coded by Human Tumor Viruses
2005
ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)31This document was approved by the American College of Cardiology Board of Trustees in April 2001 and by the American Heart Association Science Advisory and Coordinating Committee in March 2001.32When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239i–lxvi.33This document is available on the ACC Web site at www.acc.organd the AHA Web site at www.americanheart.org(ask for reprint no. 71-0206). To obtain a reprint of the shorter version (executive summary and summary of recommendations) to be published in the June 15, 2001 issue of the Journal of the American College of Cardiology and the June 19, 2001 issue of Circulation for $5 each, call 800-253-4636 (US only) or write the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To purchase additional reprints up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1,000 or more copies, call 214-706-1466, fax 214-691-6342, or E-mail: pubauth@heart.org(ask for reprint no. 71-0205).
2001
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Clinical End Points in Coronary Stent Trials
2007 Standout
Interobserver variation in the reporting of cervical colposcopic biopsy specimens: comparison of grading systems.
1996
Predictive Factors of Restenosis After Coronary Stent Placement
1997
Bacterial Topoisomerase Inhibitors: Quinolone and Pyridone Antibacterial Agents
2005
Tumor angiogenesis in advanced stage ovarian carcinoma.
1995
Emerging Targets in Photopharmacology
2016 StandoutNobel
Distinct Signaling Events Downstream of mTOR Cooperate To Mediate the Effects of Amino Acids and Insulin on Initiation Factor 4E-Binding Proteins
2005 StandoutNobel
Comparative Survival of Dialysis Patients in the United States After Coronary Angioplasty, Coronary Artery Stenting, and Coronary Artery Bypass Surgery and Impact of Diabetes
2002
Dysregulation of the TSC-mTOR pathway in human disease
2004 Standout
Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects.
2002
ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary
2001
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
Microvessel Density as a Prognostic Factor in Women with Breast Cancer
2004
Works of David E. Fish being referenced
Is the relationship between angiogenesis and metastasis in breast cancer real?
1992
Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery
2005
Subcellular localisation of the X protein in HBV infected hepatocytes
2001
Potential for False-Positive Staining With a Rabbit Monoclonal Antibody to Progesterone Receptor (SP2)
2008
Localized Intracoronary Gamma-Radiation Therapy to Inhibit the Recurrence of Restenosis after Stenting
2001
Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: The multicenter U.S. Palmaz-Schatz stent experience
1995
The safety profile of the fluoroquinolones
2000
Pathologist variation in reporting cervical borderline epithelial abnormalities and cervical intraepithelial neoplasia.
1995
Histological and immunohistochemical study of hepatitis B virus in human immunodeficiency virus infection.
1990
Preoperative Needle Biopsy of Sentinel Lymph Nodes Using Intradermal Microbubbles and Contrast-Enhanced Ultrasound in Patients With Breast Cancer
2012
Schistosomiasis: an unusual cause of pruritus vulvae
1994